Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Hollie A, Jackson"'
Publikováno v:
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
T cells can be genetically modified to target tumors through the expression of a chimeric antigen receptor (CAR). Most notably, CAR T cells have demonstrated clinical efficacy in hematologic malignancies with more modest responses when targeting soli
Externí odkaz:
https://doaj.org/article/aa41bb42649f4d75ac05ef63fa675fa4
Autor:
Lisa B. Paquette, David Miller, Hollie A. Jackson, Thomas Lee, Linda Randolph, A. Lynn Murphree, Ashok Panigrahy
Publikováno v:
American Journal of Perinatology Reports, Vol 02, Iss 01, Pp 055-062 (2012)
Purpose - Our aim was to evaluate and compare the ability of prenatal ultrasound (US) and fetal magnetic resonance imaging (MRI) to detect retinoblastoma lesions in utero. Methods - Fetuses at risk for having bilateral retinoblastoma were enrolled
Externí odkaz:
https://doaj.org/article/60a863fd9b244ebebdd5a9f269782736
Autor:
Eugene C. Chen, Kathleen M. Giacomini, Fariba Goodarzian, Brian Weiss, Ethan G. Geier, Katherine K. Matthay, Randall A. Hawkins, Hollie A. Jackson, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Xiaodong Yang, Jesse Courtier, Araz Marachelian, Steven G. DuBois, Denice D. Tsao-Wei, Julie R. Park, Judith G. Villablanca, S. Groshen, Daphne A. Haas-Kogan, Scarlett Czarnecki, Hiroyuki Shimada
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 21, iss 12
Purpose: 131I-metaiodobenzylguanidine (MIBG) is a radiopharmaceutical with activity in neuroblastoma. Vorinostat is a histone deacetylase inhibitor that has radiosensitizing properties. The goal of this phase I study was to determine the MTDs of vori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b71756ff4e2d1240fa78f44edd7d10
https://doi.org/10.1158/1078-0432.ccr-14-3240
https://doi.org/10.1158/1078-0432.ccr-14-3240
Autor:
Rafael Ceschin, Arabhi C. Nagasunder, Hollie A. Jackson, Jodie K. Votava-Smith, Jessica L. Wisnowski, Ashok Panigrahy, Lisa Paquette, Stefan Bluml
Publikováno v:
Pediatric Cardiology. 36:960-969
Preterm birth is associated with alteration in corticothalamic development, which underlies poor neurodevelopmental outcomes. Our hypothesis was that preterm neonates with CHD would demonstrate abnormal thalamic microstructure when compared to critic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e47e8f5929791a29a6fd5bfe882751
https://doi.org/10.1007/s00246-015-1106-8
https://doi.org/10.1007/s00246-015-1106-8
Autor:
Susan L. Cohn, John M. Maris, James G. Gurney, Yael P. Mosse, Julie R. Park, Geetika Khanna, Wendy B. London, Holly M. Meany, Hollie A. Jackson, Elizabeth Fox, Gary Gordon, Frank M. Balis, Suzanne Shusterman, Peter C. Adamson
Publikováno v:
Pediatric Blood & Cancer. 61:990-996
Background ABT-751, an orally bioavailable sulfonamide binds the colchicine site of beta-tubulin and inhibits microtubule polymerizaton. Prior phase I studies established the recommended dose in children with solid tumors as 200 mg/m2 PO daily × 7 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eef48f4ff637fd8856766c4f3a27f927
https://doi.org/10.1002/pbc.24900
https://doi.org/10.1002/pbc.24900
Autor:
Terence J. Purdon, Su Yan, Cheng Liu, Pei Wang, Xiaojing Ma, Ronald C. Hendrickson, Renier J. Brentjens, Jingyi Xiang, Zhuoning Li, Venkatraman E. Seshan, Mei Song, Matthew M. Miele, Dayenne G. van Leeuwen, Sarwish Rafiq, Dylan J. Drakes, Hollie J. Jackson, Oladapo Yeku
Publikováno v:
Nature biotechnology
The efficacy of chimeric antigen receptor (CAR) T cell therapy against poorly responding tumors can be enhanced by administering the cells in combination with immune checkpoint blockade inhibitors. Alternatively, the CAR construct has been engineered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc87df313039e007ed22eb73759949d4
https://pubmed.ncbi.nlm.nih.gov/30102295
https://pubmed.ncbi.nlm.nih.gov/30102295
Publikováno v:
Nature reviews. Clinical oncology. 13(6)
The engineered expression of chimeric antigen receptors (CARs) on the surface of T cells enables the redirection of T-cell specificity. Early clinical trials using CAR T cells for the treatment of patients with cancer showed modest results, but the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f1d250720cfc15f6dc18c70caab82c
https://pubmed.ncbi.nlm.nih.gov/27000958
https://pubmed.ncbi.nlm.nih.gov/27000958
Autor:
Hollie A. Jackson, David A. Miller, Ashok Panigrahy, Linda M. Randolph, Thomas C. Lee, A. Lynn Murphree, Lisa Paquette
Publikováno v:
AJP Reports
American Journal of Perinatology Reports, Vol 02, Iss 01, Pp 055-062 (2012)
American Journal of Perinatology Reports, Vol 02, Iss 01, Pp 055-062 (2012)
Purpose Our aim was to evaluate and compare the ability of prenatal ultrasound (US) and fetal magnetic resonance imaging (MRI) to detect retinoblastoma lesions in utero. Methods Fetuses at risk for having bilateral retinoblastoma were enrolled in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0306873d1759dc3aae4f477e50e819d
http://europepmc.org/articles/PMC3653521
http://europepmc.org/articles/PMC3653521
Publikováno v:
American Journal of Perinatology. 29:295-300
Previous work has shown that fetal hydrographic magnetic resonance imaging (MRI) provided additional information complementary to T2-weighted single-shot fast spin echo (ssFSE) images. The objective of this study was to determine if hydrographic MRI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0ff54a225e5005730d9b08709e04ae
https://doi.org/10.1055/s-0031-1295636
https://doi.org/10.1055/s-0031-1295636
Autor:
Marguerite T. Parisi, Paul M. Sondel, Hollie A. Jackson, Brenda J. Kitchen, C. Patrick Reynolds, Enno Stranzinger, Wendy B. London, Barry L. Shulkin, Joel M. Reid, Sarah A. Buhrow, Gregory A. Yanik, Arlene Naranjo, Patrick McGrady, Judith G. Villablanca, Susan L. Cohn, Renee M. McGovern, Matthew M. Ames
Publikováno v:
Clinical Cancer Research. 17:6858-6866
Purpose: To determine the response rate to oral capsular fenretinide in children with recurrent or biopsy proven refractory high-risk neuroblastoma. Experimental Design: Patients received 7 days of fenretinide: 2,475 mg/m2/d divided TID ( Results: Si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e070ac36307d77b5efd307cd88d3446
https://doi.org/10.1158/1078-0432.ccr-11-0995
https://doi.org/10.1158/1078-0432.ccr-11-0995